Home
SCLX
SCLX News

Latest Scilex Holding Company (SCLX) News on July 27, 2024

Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report

GlobeNewswire

2 days ago

Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report

Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.

GlobeNewswire

3 days ago

Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.

Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region

GlobeNewswire

9 days ago

Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region

MT Newswires

24 days ago

Scilex Holding Unit Semnur Pharmaceuticals, Denali Capital Acquisition Propose Merger

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

GlobeNewswire

24 days ago

Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

GlobeNewswire

24 days ago

Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024

GlobeNewswire

25 days ago

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024

Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.

GlobeNewswire

a month ago

Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.

Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)

GlobeNewswire

a month ago

Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)

Scilex Holding Company (NASDAQ:SCLX) Analysts Just Cut Their EPS Forecasts Substantially

Simply Wall St.

a month ago

Scilex Holding Company (NASDAQ:SCLX) Analysts Just Cut Their EPS Forecasts Substantially

Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024

GlobeNewswire

a month ago

Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Premarket Wednesday

MT Newswires

a month ago

Scilex Holding Signs Commitment Letter for $100 Million Financing; Shares Advance Premarket

Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies

GlobeNewswire

a month ago

Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies

Zacks Small Cap Research

a month ago

SCLX: Undervalued and Adding Products

Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®

GlobeNewswire

a month ago

Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®

Edge Total Intelligence Inc. Updates Status of MCTO

Newsfile

2 months ago

Edge Total Intelligence Inc. Updates Status of MCTO

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

GlobeNewswire

2 months ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

GlobeNewswire

2 months ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

GlobeNewswire

2 months ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

2 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

GlobeNewswire

2 months ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

CNW Group

2 months ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

2 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.

GlobeNewswire

2 months ago

Scilex Holding Company Announces Stocking of GLOPERBA® is Underway in all of the Wholesalers with which Scilex has Stocking Arrangements Throughout the U.S.

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

2 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Simply Wall St.

2 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Simply Wall St.

2 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

2 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Simply Wall St.

2 months ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Simply Wall St.

2 months ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Seoul resumes loudspeaker propaganda against North

AFP

2 months ago

Seoul resumes loudspeaker propaganda against North

MT Newswires

2 months ago

Scilex Shares Advance after FDA Approves Production of Gout Medication

Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024

GlobeNewswire

2 months ago

Scilex Holding Company announces the U.S. FDA has approved the sNDA for commercial manufacturing of Gloperba® which will be launched in the US in the week of June 10th 2024

Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company

GlobeNewswire

2 months ago

Scilex Holding Company Sends Letters to the U.S. Securities and Exchange Commission and Financial Industry Regulatory Authority Regarding Illegal Market Manipulation of the Common Stock of Scilex Holding Company

News Flash: 3 Analysts Think Scilex Holding Company (NASDAQ:SCLX) Earnings Are Under Threat

Simply Wall St.

2 months ago

News Flash: 3 Analysts Think Scilex Holding Company (NASDAQ:SCLX) Earnings Are Under Threat

MT Newswires

2 months ago

Scilex to Join MSCI Global Small Cap Index

MT Newswires

2 months ago

Scilex Calls for Investigation Into Alleged 'Naked Short' Stock Manipulation

Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index

GlobeNewswire

2 months ago

Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index

Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company

GlobeNewswire

2 months ago

Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company

With Scilex Holding Up 36%, Insider Buyers Count Their Returns

Simply Wall St.

2 months ago

With Scilex Holding Up 36%, Insider Buyers Count Their Returns

MT Newswires

2 months ago

Update: Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute

MT Newswires

2 months ago

Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute

Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®

GlobeNewswire

2 months ago

Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®

Zacks Small Cap Research

2 months ago

SCLX Grows Revenue and Expands Portfolio

Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock

GlobeNewswire

2 months ago

Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock

Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering

GlobeNewswire

3 months ago

Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering

Scilex Holding Company Announces $15 Million Registered Direct Offering

GlobeNewswire

3 months ago

Scilex Holding Company Announces $15 Million Registered Direct Offering

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses

GlobeNewswire

3 months ago

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses

Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool

GlobeNewswire

4 months ago

Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend

GlobeNewswire

4 months ago

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend

Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients

GlobeNewswire

4 months ago

Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients

Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed

GlobeNewswire

4 months ago

Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®

GlobeNewswire

4 months ago

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

GlobeNewswire

4 months ago

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada

GlobeNewswire

4 months ago

Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada

Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.

GlobeNewswire

4 months ago

Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement

GlobeNewswire

4 months ago

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement

Scilex Holding Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

4 months ago

Scilex Holding Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Zacks Small Cap Research

4 months ago

SCLX Grows Revenue and Boosts Marketing

Scilex Holding Company (NASDAQ:SCLX) most popular amongst private companies who own 57% of the shares, institutions hold 25%

Simply Wall St.

5 months ago

Scilex Holding Company (NASDAQ:SCLX) most popular amongst private companies who own 57% of the shares, institutions hold 25%

Scilex Holding Company Announces Closing of $10 Million Bought Deal Offering

GlobeNewswire

5 months ago

Scilex Holding Company Announces Closing of $10 Million Bought Deal Offering

Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the First Half of 2024

GlobeNewswire

5 months ago

Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the First Half of 2024

Zacks Small Cap Research

5 months ago

SCLX Continues to Make Strides

Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates

GlobeNewswire

5 months ago

Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates

Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024

GlobeNewswire

5 months ago

Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024

Scilex Holding Company Announces $10 Million Bought Deal Offering

GlobeNewswire

5 months ago

Scilex Holding Company Announces $10 Million Bought Deal Offering

Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.

GlobeNewswire

5 months ago

Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.

Scilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM)

GlobeNewswire

5 months ago

Scilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM)

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement

GlobeNewswire

5 months ago

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement

Scilex Holding Company Announces that ZTlido® Achieves a Major Milestone - Over One Million Patients Treated Since its Launch - and Two Additional Milestones Met

GlobeNewswire

5 months ago

Scilex Holding Company Announces that ZTlido® Achieves a Major Milestone - Over One Million Patients Treated Since its Launch - and Two Additional Milestones Met

Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹

GlobeNewswire

5 months ago

Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹

VIZSLA SILVER ADDS UNPARALLELED MINE-BUILDING AND OPERATING EXPERTISE, APPOINTS SIMON CMRLEC TO THE ROLE OF COO

CNW Group

6 months ago

VIZSLA SILVER ADDS UNPARALLELED MINE-BUILDING AND OPERATING EXPERTISE, APPOINTS SIMON CMRLEC TO THE ROLE OF COO

Zacks Small Cap Research

6 months ago

SCLX Sees Accelerating Revenue Growth

Leggett & Platt Announces 4Q and Full Year 2023 Earnings Call

GlobeNewswire

6 months ago

Leggett & Platt Announces 4Q and Full Year 2023 Earnings Call

Carter Bankshares, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

ACCESSWIRE

6 months ago

Carter Bankshares, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results

One Reservoir Media Insider Raised Stake By 37% In Previous Year

Simply Wall St.

6 months ago

One Reservoir Media Insider Raised Stake By 37% In Previous Year

Associated Press Finance

6 months ago

Univest: Q4 Earnings Snapshot

Qualcomm (QCOM) Soars 4.6%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Qualcomm (QCOM) Soars 4.6%: Is Further Upside Left in the Stock?

5 Outstanding Small Cap Value Stocks

Zacks

6 months ago

5 Outstanding Small Cap Value Stocks

AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference

GlobeNewswire

6 months ago

AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference

Stitch Fix Halts Full-time Hours for Stylists

WWD

6 months ago

Stitch Fix Halts Full-time Hours for Stylists

Alector Announces Pricing of Public Offering of Common Stock

GlobeNewswire

6 months ago

Alector Announces Pricing of Public Offering of Common Stock

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS

CNW Group

6 months ago

VIZSLA SILVER TO SPIN OUT NET SMELTER ROYALTY TO SHAREHOLDERS

Dingdong (Cayman) Limited (NYSE:DDL) CEO Liang Changlin, the company's largest shareholder sees 10% reduction in holdings value

Simply Wall St.

6 months ago

Dingdong (Cayman) Limited (NYSE:DDL) CEO Liang Changlin, the company's largest shareholder sees 10% reduction in holdings value

Investors in Great Southern Bancorp (NASDAQ:GSBC) have seen decent returns of 33% over the past five years

Simply Wall St.

6 months ago

Investors in Great Southern Bancorp (NASDAQ:GSBC) have seen decent returns of 33% over the past five years

MidWestOne Financial Group, Inc. Announces Fourth Quarter 2023 Earnings Conference Call

GlobeNewswire

6 months ago

MidWestOne Financial Group, Inc. Announces Fourth Quarter 2023 Earnings Conference Call

Lilium Announces Planned Participation in Upcoming First Quarter 2024 Investor Events

GlobeNewswire

6 months ago

Lilium Announces Planned Participation in Upcoming First Quarter 2024 Investor Events

Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2023 Update

GlobeNewswire

7 months ago

Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2023 Update

While institutions own 33% of Lands' End, Inc. (NASDAQ:LE), individual investors are its largest shareholders with 57% ownership

Simply Wall St.

7 months ago

While institutions own 33% of Lands' End, Inc. (NASDAQ:LE), individual investors are its largest shareholders with 57% ownership

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

GlobeNewswire

7 months ago

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

Voyager (VYGR) Gains on Gene Therapy Deal With Novartis

Zacks

7 months ago

Voyager (VYGR) Gains on Gene Therapy Deal With Novartis

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information

GlobeNewswire

7 months ago

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information

Bitdeer Technologies Group (NASDAQ: BTDR) Q3 Earnings Highlights: Net Loss Slashed, Gross Profit And Gross Margin Up

ACCESSWIRE

7 months ago

Bitdeer Technologies Group (NASDAQ: BTDR) Q3 Earnings Highlights: Net Loss Slashed, Gross Profit And Gross Margin Up

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

GlobeNewswire

7 months ago

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

12 Highest Quality French Fries Brands in the US

Insider Monkey

7 months ago

12 Highest Quality French Fries Brands in the US

Scilex Holding Company Announces Filing of a New Drug Submission (NDS) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada

GlobeNewswire

7 months ago

Scilex Holding Company Announces Filing of a New Drug Submission (NDS) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada

Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists

GlobeNewswire

7 months ago

Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists

Scilex Holding Company Announces Results from Market Research with Rheumatologists Reveal a High Degree of Interest in Gloperba® as a Liquid Colchicine Formulation Designed for Precision Dosing

GlobeNewswire

7 months ago

Scilex Holding Company Announces Results from Market Research with Rheumatologists Reveal a High Degree of Interest in Gloperba® as a Liquid Colchicine Formulation Designed for Precision Dosing

Share on Social Networks: